Recurrent Plasma Cell Myeloma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Not yet recruiting
  • Multiple Myeloma
  • +4 more
  • Pembrolizumab
  • San Francisco, California
    University of California, San Francisco
2022-01-02
Jan 2, 2022
C
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Duarte, California
    City of Hope Medical Center
2022-01-10
Jan 10, 2022
A
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Daratumumab
  • +2 more
  • Peoria, Illinois
  • +10 more
2022-01-05
Jan 5, 2022
A
Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Des Moines, Iowa
  • +7 more
2022-01-05
Jan 5, 2022
N
Recruiting
  • Plasmacytoma
  • +2 more
  • Sacramento, California
  • +5 more
2022-01-05
Jan 5, 2022
E
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
  • +3 more
2022-01-05
Jan 5, 2022
N
Recruiting
  • Lymphoma
  • +6 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +139 more
2022-01-04
Jan 4, 2022
M
Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • t(11;14)
  • Ann Arbor, Michigan
  • +2 more
2021-12-22
Dec 22, 2021
M
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Daratumumab
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-22
Dec 22, 2021
U
Recruiting
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +11 more
  • Fluorine F 18-fluoroazomycin Arabinoside
  • Positron Emission Tomography
  • San Francisco, California
    University of California, San Francisco
2021-12-17
Dec 17, 2021
O
Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Portland, Oregon
    OHSU Knight Cancer Institute
2021-12-22
Dec 22, 2021
V
Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
2021-12-21
Dec 21, 2021
U
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-09
Dec 9, 2021
E
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Atlanta, Georgia
  • +1 more
2021-12-07
Dec 7, 2021
A
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-11-30
Nov 30, 2021
M
Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
2021-12-01
Dec 1, 2021
F
Not yet recruiting
  • Plasma Cell Myeloma
  • +2 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-11-15
Nov 15, 2021
M
Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-18
Nov 18, 2021
U
Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
2021-11-16
Nov 16, 2021
C
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • CS1-CAR T Therapy
  • +3 more
  • Duarte, California
    City of Hope Medical Center
2021-11-15
Nov 15, 2021
M
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-11-01
Nov 1, 2021
U
Recruiting
  • Plasma Cell Leukemia
  • +2 more
  • Biospecimen Collection
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-10-18
Oct 18, 2021
M
Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Scottsdale, Arizona
  • +2 more
2021-10-18
Oct 18, 2021